Syringe News and Research

RSS

Flexible wireless implant offers hope for chronic pain sufferers

Chronic pain is a debilitating condition that severely impacts quality of life, often leading to reliance on opioid medications with their severe side effects and addiction risks.

24 Jun 2025

COVID boosters do not harm T-cell function in the vulnerable

Findings indicate that frequent COVID-19 booster shots do not weaken T-cell responses, alleviating concerns for vulnerable groups facing new variants.

9 Jun 2025

How does norepinephrine influence anxiety-related behaviours?

Discover how microscopy revealed the influence norepinephrine has on anxiety.

From Bruker Nano Surfaces and Metrology 3 Jun 2025

3 things to watch on mental health in Trump’s early budget proposals

Since President Donald Trump released his 2026 budget blueprint in early May, calling for $163 billion in federal spending cuts, much of the attention has focused on his slashing of foreign aid and boosting of border security.

21 May 2025

Pharmacists stockpile most common drugs on chance of targeted Trump tariffs

In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one man's defensive wall in a tariff war.

16 May 2025

Wuxi Biologics completes first commercial PPQ campaign at 15,000L production line in Hangzhou site

WuXi Biologics ("WuXi Bio"), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced the successful completion of the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000L single-use bioreactors (SUBs) in the second drug substance line of its MFG20 facility at the Hangzhou site.

16 May 2025

Marstacimab approved to treat patients aged 12 years and above (weighing at least 35 kg) with hemophilia A or B

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine marstacimab (Hympavzi) to prevent or reduce bleeding in patients 12 years of age and older weighing at least 35 kg with hemophilia A and B.

23 Apr 2025

Zinc found in glassware may impair embryo development in IVF

The research team discovered that glassware used to manipulate and culture fertilized eggs in the fields of assisted reproductive technology (ART), livestock farming, and basic research contains toxic substances that interfere with the development of fertilized eggs (embryos).

18 Apr 2025

Clinical trial demonstrates safety of targeted treatment approach for deadly brain tumor in children

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center investigators.

3 Apr 2025

Novel long-acting contraceptive implant can be delivered through tiny needles

Mass General Brigham and MIT investigators have developed a long-acting contraceptive implant that can be delivered through tiny needles to minimize patient discomfort and increase the likelihood of medication use.

24 Mar 2025

Innovative gel prevents post-surgery adhesions in animal models

Surgical adhesions - common, sometimes life-threatening complications that arise after open or laparoscopic abdominal surgery - can be prevented in mice and pigs by a gel impregnated with a molecule that blocks a key signaling pathway in the formation of scar tissue.

12 Mar 2025

Wildlife and forest walks help alleviate PTSD symptoms in veterans

A new study published in the journal Human-Animal Interactions has revealed that exposure to wildlife and forest walks can help ease the symptoms of Post Traumatic Stress Disorder (PTSD) in US war veterans.

6 Mar 2025

Venom is everywhere: Study examines hidden toxin delivery systems across life forms

Forget snakes and spiders—a new review details venomous plants, fungi, and even bacteria, proving that nature's deadliest secret weapon is more widespread than we ever imagined.

23 Feb 2025

UQ and Vaxxas win global prize to accelerate patch-based mRNA vaccine for COVID-19

The University of Queensland's BASE facility – within the Australian Institute for Bioengineering and Nanotechnology (AIBN) – and Brisbane-based biotechnology company Vaxxas have been announced as stage winners of a prestigious global prize to accelerate a patch-based mRNA vaccine for COVID-19.

13 Jan 2025

Single-dose malaria vaccine offers unprecedented 90% protection

Results from the malaria vaccine trial indicate that GA2 immunization provides significant protection, paving the way for more effective vaccination strategies.

8 Jan 2025

Syringe exchange fears hobble fight against West Virginia HIV outbreak

More than three years have passed since federal health officials arrived in central Appalachia to assess an alarming outbreak of HIV spread mostly between people who inject opioids or methamphetamine.

3 Jan 2025

AMF at SLAS 2025: Precision microfluidics in San Diego

AMF is excited to participate in the SLAS 2025 International Conference & Exhibition, taking place from January 25-29, 2025 at the San Diego Convention Center. This renowned event will bring together professionals from across the life sciences, biotech, and automation industries to showcase the latest innovations and technologies.

From Advanced Microfluidics SA 24 Dec 2024

Precision in every drop: Inside Hamilton’s syringe technology

NewsMedical spoke with Hamilton Company about its syringe technology, custom syringe solutions, and syringe accessories for multi-industry use.

From Hamilton Lab 16 Dec 2024

How are states spending opioid settlement cash? We built a database of answers

In the past few years, state and local governments across the U.S. have begun spending billions in opioid settlements paid by companies accused of fueling the overdose crisis. But where is that money going, who is getting it, and is it doing any good?

16 Dec 2024

Phase one trial explores novel immunotherapy for breast cancer

A groundbreaking phase one clinical trial exploring a novel cell-based immunotherapy for breast cancer has been accepted for publication in JAMA Oncology.

5 Dec 2024